Product Information
PHENOBARBITAL 15 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.0695 per EA under NDC 00143149501. Its NADAC has been published 320 times since May 13, 2020.
Strength
15 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143149501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PHENOBARBITALApproval Type
Unapproved
On Market Since
3/5/2020
Price Statistics
The NADAC for PHENOBARBITAL 15 MG TABLET has been published 320 times since May 13, 2020, and over the history we have for it it has declined 65.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0695 per EA |
|---|---|
| All-time high | $0.2186 (Oct 12, 2022) |
| All-time low | $0.0614 (Apr 22, 2026) |
| 52-week high | $0.0823 |
| 52-week low | $0.0614 |
| Median price | $0.1192 |
| Average price | $0.1237 |
| Largest weekly change | +52.6% (May 17, 2023) |
| Weeks tracked | 320 |
| Tracking since | May 13, 2020 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENOBARBITAL 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 15 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $0.0695 per EA (NDC 00143149501), effective Jun 24, 2026.
How has the price of PHENOBARBITAL 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENOBARBITAL 15 MG TABLET has declined 65.9%. It has been tracked across 320 weekly CMS publications since May 13, 2020.
What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 15 MG TABLET?
Since May 13, 2020, the NADAC for PHENOBARBITAL 15 MG TABLET has ranged from a low of $0.0614 (Apr 22, 2026) to a high of $0.2186 (Oct 12, 2022), with a median of $0.1192 per EA.
Are there cheaper alternatives to PHENOBARBITAL 15 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as PHENOBARBITAL 15 MG TABLET, but none are currently priced below it.
Who manufactures PHENOBARBITAL 15 MG TABLET?
PHENOBARBITAL 15 MG TABLET (NDC 00143149501) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification